Drug Shortage Report for BIO-LOSARTAN
Report ID | 43613 |
Drug Identification Number | 02445980 |
Brand name | BIO-LOSARTAN |
Common or Proper name | LOSARTAN |
Company Name | BIOMED PHARMA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-01-10 |
Estimated end date | |
Actual end date | 2018-04-24 |
Shortage status | Resolved |
Updated date | 2018-09-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-21 | English | Compare |
v2 | 2018-03-21 | French | Compare |
v3 | 2018-04-24 | English | Compare |
v4 | 2018-04-24 | English | Compare |
v5 | 2018-04-24 | French | Compare |
v6 | 2018-04-25 | English | Compare |
v7 | 2018-09-19 | English | Compare |
v8 | 2018-09-19 | French | Compare |
Showing 1 to 8 of 8